{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:25:37Z","timestamp":1793053537723,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK121888"],"award-info":[{"award-number":["K23DK121888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DK132121"],"award-info":[{"award-number":["R03DK132121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Prospective data on determinants of muscle strength impairment and quality of life in patients with various subtypes and severity of endogenous hypercortisolism are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Single-center cross-sectional study, 2019 to 2022.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with Cushing syndrome (CS) and mild autonomous cortisol secretion (MACS) were assessed with clinical and biochemical severity scores, muscle function (nondominant hand grip strength and sit-to-stand test), and quality of life (Short Form-36 [SF36] and CushingQoL). Referent subjects were recruited from the local population undergoing abdominal imaging for reasons other than suspected adrenal disorder.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 164 patients, 81 (49%) had MACS, 14 (9%) had adrenal CS, 60 (37%) had pituitary CS, and 9 (5%) had ectopic CS. Median age was 53 years (interquartile range: 42-63 years), and 126 (77%) were women. The SF36 mental component score was similarly low in patients with MACS vs CS, but physical component score was lower in CS when compared to MACS (mean of 34.0 vs 40.5, P = .001). Compared to MACS, patients with CS had lower scores on the standardized CushingQoL (mean of 47.1 vs 34.2, P &amp;lt; .001). Compared to referent subjects, patients with MACS demonstrated reduced muscle strength, similar to patients with CS (mean sit to stand Z-score of \u22120.47 vs \u22120.54, P = .822). Clinical severity (r = \u22120.22, P = .004) but not biochemical severity was associated with sit-to-stand test performance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Both patients with overt CS and MACS demonstrate reduced muscle strength and low quality of life. The clinical severity score utilized is associated with both physical and psychosocial components of CushingQoL and with the physical component of SF36.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvad069","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:35:56Z","timestamp":1686940556000},"page":"40-49","source":"Crossref","is-referenced-by-count":15,"title":["Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0419","authenticated-orcid":false,"given":"Dingfeng","family":"Li","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Department of Endocrinology, Endocrinology and Metabolism Institute, Cleveland Clinic Foundation , Cleveland, OH 44195 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-2673","authenticated-orcid":false,"given":"Catherine D","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin , Milwaukee, WI , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Saini","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitabh","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX, USTW 75390 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Nathani","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX, USTW 75390 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Thangamuthu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malavika","family":"Suresh","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"},{"name":"Department of Internal Medicine, Medstar Health , Baltimore, MD, medstar: 21230 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Van Gompel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William F","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"9996","key":"2023072108130908700_lvad069-B1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"2023072108130908700_lvad069-B2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023072108130908700_lvad069-B3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2023072108130908700_lvad069-B4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz284","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study","volume":"105","author":"Reimondo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023072108130908700_lvad069-B5","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023072108130908700_lvad069-B6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"2023072108130908700_lvad069-B7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2023072108130908700_lvad069-B8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/gs.2019.11.03","article-title":"Cardiovascular risk and mortality in patients with active and treated hypercortisolism","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"6","key":"2023072108130908700_lvad069-B9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/cen.13600","article-title":"Worse health-related quality of life at long-term follow-up in patients with Cushing\u2019s disease than patients with cortisol producing adenoma. Data from the ERCUSYN","volume":"88","author":"Valassi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023072108130908700_lvad069-B10","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9014768","article-title":"Support needs of patients with Cushing\u2019s disease and Cushing\u2019s syndrome: results of a survey conducted in Germany and the USA","volume":"2018","author":"Kreitschmann-Andermahr","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2023072108130908700_lvad069-B11","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101505","article-title":"Quality of life in Cushing\u2019s syndrome","volume":"35","author":"Bride","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2023072108130908700_lvad069-B12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-20-0652","article-title":"Evaluation of an individualized education program in pituitary diseases: a pilot study","volume":"183","author":"Albarel","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023072108130908700_lvad069-B13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11102-014-0561-1","article-title":"Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary"},{"issue":"5","key":"2023072108130908700_lvad069-B14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023072108130908700_lvad069-B15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/EJE-16-0689","article-title":"Persistence of myopathy in Cushing\u2019s syndrome: evaluation of the German Cushing\u2019s registry","volume":"176","author":"Berr","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2023072108130908700_lvad069-B16","doi-asserted-by":"crossref","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","article-title":"Persisting muscle dysfunction in Cushing\u2019s syndrome despite biochemical remission","volume":"105","author":"Vogel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023072108130908700_lvad069-B17","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023072108130908700_lvad069-B18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"6","key":"2023072108130908700_lvad069-B19","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"THERAPY OF ENDOCRINE DISEASE: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023072108130908700_lvad069-B20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ageing\/afr051","article-title":"A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach","volume":"40","author":"Roberts","year":"2011","journal-title":"Age Ageing"},{"issue":"3","key":"2023072108130908700_lvad069-B21","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzab299","article-title":"Sex- and age-specific centile curves and downloadable calculator for clinical muscle strength tests to identify probable sarcopenia","volume":"102","author":"Warden","year":"2022","journal-title":"Phys Ther"},{"issue":"4 Suppl","key":"2023072108130908700_lvad069-B22","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"key":"2023072108130908700_lvad069-B23","author":"Ware","year":"2001"},{"issue":"5","key":"2023072108130908700_lvad069-B24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual Life Res"},{"issue":"5","key":"2023072108130908700_lvad069-B25","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz329","article-title":"Thigh muscle fat infiltration is associated with impaired physical performance despite remission in Cushing\u2019s syndrome","volume":"105","author":"Martel-Duguech","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023072108130908700_lvad069-B26","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz052","article-title":"Glucocorticoid receptor polymorphisms influence muscle strength in Cushing\u2019s syndrome","volume":"105","author":"M\u00fcller","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad069\/50632072\/lvad069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/1\/40\/50921344\/lvad069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/1\/40\/50921344\/lvad069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T08:14:09Z","timestamp":1689927249000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/1\/40\/7199714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad069","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,6,16]]}}}